Topic Paragraphs
FDA Accomplishments for the American People
FDA Seizes 7-OH Opioids to Protect American Consumers
The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, announced today that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at roughly $1 million—from three firms in Missouri.
Read MoreRecalls, Market Withdrawals, & Safety Alerts
Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.
Dec 15
So Delicious Dairy Free® Salted Caramel Cluster Frozen Dessert Pints Voluntarily Recalled by Danone U.S. Due to Potential Presence of Foreign Material
Food & Beverages
Dec 12
White Castle Frozen Food Division Recalls Frozen 4-Count Cartons of Original Sliders Due to Undeclared Milk and Soy
Food & Beverages
Dec 12
Town Food Service Equipment Co., Inc. Recalls Aluminum Saucepans Because of Possible Health Risk
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen
FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.
FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity
The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.
FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program
ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.
Recently Published Guidances
Dec 15
Study of Sex Differences in the Clinical Evaluation of Medical Products
Drugs
Dec 15
Sponsor Responsibilities - Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies
Drugs
Dec 15
Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices
Drugs